The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
An Introduction to Terminology and Methodology of Chemical Synergy—Perspectives from Across Disciplines
Open accessAbstract
The idea of synergistic interactions between drugs and chemicals has been an important issue in the biomedical world for over a century. As complex diseases, especially cancer, are being treated with various drug cocktails, understanding the interactions among these drugs is increasingly vital to ensuring successful treatment regimens. However, the idea of synergy is not limited to only the biomedical realm and these ideas have developed across many different disciplines, as well. In this review, we first discuss the various terminology surrounding the idea of synergy, providing a comprehensive list of terms defined across numerous disciplines. We then review the most common methodology for detection and quantification of synergy, including the two most prominent reference models for describing additive interactions: Loewe Additivity and Bliss Independence. We also discuss advantages and limitations to each method, with a focus on the Chou-Talalay Combination Index method. Finally, we describe how methods development and terminology have developed among disciplines outside of biomedicine and pharmacology, to synthesize the literature for readers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Drug combination studies and their synergy quantification using the Chou-Talalay method
Chou, T.-C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1947 · Cited by 5,739
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Potential Synergy of Phytochemicals in Cancer Prevention: Mechanism of Action
Liu, R. H. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.12.3479s · Cited by 2,276
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Wasserheit, J. N. (1992) · PubMed · Cited by 1,245
Analysis of drug combinations: current methodological landscape
Foucquier, J., & Guedj, M. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.149 · Cited by 1,115
(1953) · PubMed · Cited by 942
Gutierrez, J., Barry-Ryan, C., & Bourke, P. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.02.028 · Cited by 925
Quantifying Synergy: A Systematic Review of Mixture Toxicity Studies within Environmental Toxicology
Cedergreen, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096580 · Cited by 912
Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
Gordon Steel, G., & Peckham, M. J. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90044-0 · Cited by 908
Wasserheit (1992) · doi:10.1097/00007435-199219020-00001 · Cited by 886
The Hill equation: a review of its capabilities in pharmacological modelling
Goutelle, S., Maurin, M., Rougier, F., Barbaut, X., Bourguignon, L., Ducher, M., & Maire, P. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00633.x · Cited by 867
Rituximab: Mechanism of Action
Weiner, G. J. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.01.011 · Cited by 786
Über Kombinationswirkungen: Mitteilung: Hilfsmittel der Fragestellung
Loewe, S., & Muischnek, H. (1926) · Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01952257 · Cited by 760
Drug Synergism: Its Detection and Applications
Tallarida, R. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29450-7 · Cited by 687
Nutrients, foods, and dietary patterns as exposures in research: a framework for food synergy
Jacobs, D. R., & Steffen, L. M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.508s · Cited by 640
A three-dimensional model to analyze drug-drug interactions
Prichard, M. N., & Shipman, C. (1990) · Antiviral Research · doi:10.1016/0166-3542(90)90001-n · Cited by 544
Loewe, S., Käer, E., & Muischnek, H. (1927) · Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01859944 · Cited by 538
Gutierrez, J., Barry-Ryan, C., & Bourke, P. (2009) · Food Microbiology · doi:10.1016/j.fm.2008.10.008 · Cited by 527
The expected effect of a combination of agents: the general solution
Berenbaum, M. C. (1985) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(85)80176-4 · Cited by 523
An Overview of Drug Combination Analysis with Isobolograms
Tallarida, R. J. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104117 · Cited by 505
Criteria for Analyzing Interactions between Biologically Active Agents
(1981) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60912-4 · Cited by 454
Understanding the human health effects of chemical mixtures.
Carpenter, D. O., Arcaro, K., & Spink, D. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s125 · Cited by 424
The concentration-response relation between PM(2.5) and daily deaths.
Schwartz, J., Laden, F., & Zanobetti, A. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.021101025 · Cited by 400
GENES, BEHAVIOR, AND THE SOCIAL ENVIRONMENT: MOVING BEYOND THE NATURE/NURTURE DEBATE
Hernandez, L. M., & Blazer, D. G. (2006) · doi:10.13016/tt5y-fgvl · Cited by 351
Synergy, additivism and antagonism in immunosuppression. A critical review.
Berenbaum, M. C. (1977) · PubMed · Cited by 336
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Nielsen, E. I., & Friberg, L. E. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005769 · Cited by 332
Laetz, C. A., Baldwin, D. H., Collier, T. K., Hebert, V., Stark, J. D., & Scholz, N. L. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800096 · Cited by 330
Goldoni, M., & Johansson, C. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.03.003 · Cited by 210
Toxicology of simple and complex mixtures
Groten, J. P., Feron, V. J., & Sühnel, J. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01720-x · Cited by 185
Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles
Grabovsky, Y., & Tallarida, R. J. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067264 · Cited by 183
Trastuzumab and chemotherapeutics: drug interactions and synergies.
Pegram, M. D., Lopez, A. M., Konecny, G., & Slamon, D. (2000) · PubMed · Cited by 174
Geary, N. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00308.2012 · Cited by 165
Revisiting the Isobole and Related Quantitative Methods for Assessing Drug Synergism
Tallarida, R. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.193474 · Cited by 153
Interactions between drugs and occupied receptors
Tallarida, R. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.002 · Cited by 130
A Weight-of-Evidence Approach for Assessing Interactions in Chemical Mixtures
Mumtaz, M. M., & Durkin, P. R. (1992) · Toxicology and Industrial Health · doi:10.1177/074823379200800604 · Cited by 127
Abdo, N. M., Xia, M., Brown, C., Kosyk, O., Huang, R., Sakamuru, S., Zhou, Y., Jack, J. R., Gallins, P. J., Xia, K., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1408775 · Cited by 125
Self-citationShen, J., Gammon, M. D., Terry, M. B., Wang, L., Wang, Q., Zhang, F., Teitelbaum, S. L., Eng, S. M., Sagiv, S. K., Gaudet, M. M., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0414 · Cited by 105
Loewe, S. (1957) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07221-7 · Cited by 104
Synergy and other ineffective mixture risk definitions
Hertzberg, R. C., & MacDonell, M. M. (2002) · The Science of The Total Environment · doi:10.1016/s0048-9697(01)01113-5 · Cited by 101
Therapeutic Synergy Between Irinotecan and 5-Fluorouracil against Human Tumor Xenografts
Azrak, R. G., Cao, S., Slocum, H. K., Tóth, K., Durrani, F. A., Yin, M.-B., Pendyala, L., Zhang, W., McLeod, H. L., & Rustum, Y. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0913-3 · Cited by 94
Li, Y., Millikan, R. C., Bell, D. A., Cui, L., Tse, C., Newman, B. M., & Conway, K. (2004) · Breast Cancer Research · doi:10.1186/bcr941 · Cited by 92
The Search for Cytotoxic Synergy Between Anticancer Agents: a Case of Dorothy and the Ruby Slippers?
Greco, W. R., Faessel, H. M., & Levasseur, L. M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.699 · Cited by 92
Vijayaraghavalu, S., Dermawan, J. K. T. K., Cheriyath, V., & Labhasetwar, V. D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3004622 · Cited by 86
Lecture on the Antagonism between the Actions of Active Substances
Fraser, T. R. (1872) · BMJ · doi:10.1136/bmj.2.618.485 · Cited by 79
Groten, J. P. (2000) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00135-0 · Cited by 77
A Straightforward Method for the Study of Drug Interactions: An Isobolographic Analysis Primer
Gessner, P. K. (1988) · Journal of the American College of Toxicology · doi:10.3109/10915818809014529 · Cited by 71
Quantitation of the synergistic interaction of edatrexate and cisplatin in vitro
Chou, T., Tan, Q. H., & Sirotnak, F. M. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685668 · Cited by 56
Quantifying synergism/antagonism using nonlinear mixed‐effects modeling: A simulation study
Boik, J. C., Newman, R. A., & Boik, R. J. (2007) · Statistics in Medicine · doi:10.1002/sim.3005 · Cited by 55
Pharmacogenomic Characterization of US FDA-approved Cytotoxic Drugs
Peters, E. J., Motsinger‐Reif, A. A., Havener, T. M., Everitt, L., Hardison, N. E., Watson, V. G., Wagner, M. J., Richards, K. L., Province, M. A., & McLeod, H. L. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.92 · Cited by 46
Self-citation5. An Experimental Research on the Antagonism between the Actions of Physostigma and Atropia
Fraser, T. R. (1872) · Proceedings of the Royal Society of Edinburgh · doi:10.1017/s0370164600042565 · Cited by 42
Hennessey, V., Rosner, G. L., Bast, R. C., & Chen, M. (2010) · Biometrics · doi:10.1111/j.1541-0420.2010.01403.x · Cited by 38
Synergy: A Concept in Search of a Definition
Berthoud, H. (2013) · Endocrinology · doi:10.1210/en.2013-1420 · Cited by 34
Brown, C., Havener, T. M., Medina, M. W., Auman, J. T., Mangravite, L. M., Krauss, R. M., McLeod, H. L., & Motsinger‐Reif, A. A. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283589c50 · Cited by 33
Self-citationBrown, C., Havener, T. M., Medina, M. W., Jack, J. R., Krauss, R. M., McLeod, H. L., & Motsinger‐Reif, A. A. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.213 · Cited by 31
Self-citationConcentration‐effect and dose‐response relations in clinical pharmacology
Aronson, J. K. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02871.x · Cited by 30
AnRPackage for Assessing Drug Synergism/Antagonism
Boik, J. C., & Narasimhan, B. (2010) · Journal of Statistical Software · doi:10.18637/jss.v034.i06 · Cited by 16
Cited by
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Duarte, D., & Vale, N. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100110 · Cited by 340
Sun, Y., Berleth, N., Wu, W., Schlütermann, D., Deitersen, J., Stuhldreier, F., Berning, L., Friedrich, A., Akgün, S., Mendiburo, M. J., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04306-2 · Cited by 294
Basavegowda, N., & Baek, K.-H. (2021) · Biomolecules · doi:10.3390/biom11091267 · Cited by 275
Panossian, A., Seo, E.-J., & Efferth, T. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.204 · Cited by 127
Metadata
- Authors
- Roell, K. R., Reif, D. M., & Motsinger-Reif, A. A.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-20
- Volume
- 8
- Pages
- 158-158
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2603616104
- Cited by
- 295
- References
- 59
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.